Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

Lookup NU author(s): Dr Diarmuid CoughlanORCiD, Oluwatomi Arisa, Dr Katie ThomsonORCiD, Dr Ge YuORCiD, Dr Fiona Pearson, Dr Ashleigh KernohanORCiD, Sonia Garcia Gonzalez-MoralORCiD, Sheila WallaceORCiD, Stephen RiceORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Coughlan D, Arisa O, Thomson K, Yu G, Pearson F, Kernohan A, Garcia Gonzalez-Moral S, Wallace S, Rice S

Publication type: Article

Publication status: Published

Journal: PharmacoEconomics

Year: 2024

Volume: 42

Pages: 5-9

Print publication date: 01/01/2024

Online publication date: 05/10/2023

Acceptance date: 27/08/2023

Date deposited: 10/10/2023

ISSN (print): 1170-7690

ISSN (electronic): 1179-2027

Publisher: Adis International Ltd.

URL: https://doi.org/10.1007/s40273-023-01317-z

DOI: 10.1007/s40273-023-01317-z

ePrints DOI: 10.57711/99p0-4a85

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Programme (Grant number: NIHR132004)

Share